Compare VERA & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | RHI |
|---|---|---|
| Founded | 2016 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.6B |
| IPO Year | 2021 | 1994 |
| Metric | VERA | RHI |
|---|---|---|
| Price | $33.93 | $27.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 7 |
| Target Price | ★ $81.30 | $30.33 |
| AVG Volume (30 Days) | 969.5K | ★ 2.1M |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 8.68% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $5,378,506,000.00 |
| Revenue This Year | N/A | $1.27 |
| Revenue Next Year | $472.48 | $5.95 |
| P/E Ratio | ★ N/A | $195.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.76 | $21.83 |
| 52 Week High | $56.05 | $46.69 |
| Indicator | VERA | RHI |
|---|---|---|
| Relative Strength Index (RSI) | 39.09 | 54.71 |
| Support Level | $34.04 | $25.93 |
| Resistance Level | $42.77 | $28.28 |
| Average True Range (ATR) | 1.94 | 1.41 |
| MACD | -0.15 | 0.02 |
| Stochastic Oscillator | 17.80 | 80.88 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.